LinkedIn Founder Reid Hoffman Sees Bright AI Future

LinkedIn Founder Reid Hoffman Says that the Only Way to Deal with Information Overload is AI
We’re producing vastly more information than any of us can possibly consume—artificial intelligence may be the key to effectively making use of that data.
Reid Hoffman on human agency in an AI-powered future
Techno-optimist, investor and LinkedIn co-founder Reid Hoffman has written a new book, “Superagency,” outlining his vision of an AI-powered future. On Wednesday, Feb. 5  T, Hoffman joins The Post’s Bina Venkataraman to discuss how AI could help address the world’s most urgent problems and the future of human agency in the AI era.
LinkedIn co-founder Reid Hoffman: DeepSeek AI proves this is now a 'game-on competition' with China
Reid Hoffman, Greylock partner, Inflection AI and LinkedIn co-founder, and ‘Superagency' author, joins 'Squawk Box' to discuss China's DeepSeek AI development, impact on the AI technology race, AI investment outlook,
Reid Hoffman
Reid Hoffman is a Partner at Greylock Partners and Co-Founder and Executive Chairman at LinkedIn (NYSE: LNKD). Reid joined Greylock Partners in 2009. His areas of focus include consumer Internet, enterprise 2.
Reid Hoffman Raises $24.6 Million for AI Cancer-Research Startup
The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.
LinkedIn's Reid Hoffman discusses his new book 'Superagency' on the future of AI
NPR's Steve Inskeep speaks with LinkedIn cofounder Reid Hoffman about his latest book, "Superagency: What Could Possibly Go Right With Our AI Future?"
LinkedIn Founder Reid Hoffman sees bright AI future and hopes his tech peers are right about Trump
LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in the shadow of Stanford University, where he and fellow technology luminary Peter Thiel became friends as college students during the 1980s.
Why Reid Hoffman feels optimistic about our AI future
What Could Possibly Go Right with Our AI Future," the LinkedIn co-founder makes the case that AI can extend human
LinkedIn co-founder Reid Hoffman just raised $25 million to take on cancer with AI
LinkedIn (MSFT) co-founder and venture capitalist Reid Hoffman on Monday launched an AI startup aimed at discovering new treatments for cancer.
WATCH: LinkedIn Founder Reid Hoffman Joins The Daily Beast Podcast
The political circus may have been in town in D.C. this week with a host of contentious hearings for a series of President ...
Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug discovery startups
LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies ...
pharmaphorum5m
Rad AI raises $60m, and other digital financings
San Francisco-based Rad AI, which develops generative AI (GenAI) tools to improve radiology workflows, has raised $60 million ...
Observer3d
Reid Hoffman Bets on A.I. Drug Discovery with a Pulitzer-Winning Cancer Physician
Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...
The Stanford Daily2h
Andrew Yang: Trump’s win ushers in a ‘dark period in American life’
The former presidential candidate and founder of the Forward Party addressed a Stanford audience, speaking about the ...
'Scream night': Democrats get shouted down by their own activists over climate change
More than a dozen protesters, primarily affiliated with the Sunrise Movement, repeatedly stopped the DNC forum proceedings throughout the first 30 minutes. After five individual interruptions, six ...
Bill Gates Isn’t Like Those Other Tech Billionaires
The Microsoft co-founder and philanthropist is taking a break from the future to examine his past — and mulling where the ...
Judge temporarily blocks policy that would freeze federal grant funding | The Excerpt
Plus: Caroline Kennedy calls Robert F. Kennedy Jr. a predator ahead of his confirmation hearing | State Dept. allows HIV meds ...